Today is May 13, 2024. All times in Eastern Daylight Time.
CORRECTING and REPLACING Southland Announces First Quarter 2024 Results
05/13/2024 - 06:56 PM
BUSINESS WIRE
Urban Adventures Companies Announces Major Expansion at VIDA Fitness City Vista Location
05/13/2024 - 06:46 PM
BUSINESS WIRE
Xcel Energy Inc. to Webcast Annual Meeting of Shareholders
05/13/2024 - 06:45 PM
BUSINESS WIRE
Blackstone Secured Lending Fund Prices Public Offering of $400.0 million 5.875% Unsecured Notes due 2027
05/13/2024 - 06:37 PM
BUSINESS WIRE
HNI Corporation Increases Quarterly Dividend
05/13/2024 - 06:34 PM
BUSINESS WIRE
Rubisco Seeds introduces the first commercial High Oleic, Low Linolenic (HOLL) winter canola to the US market
05/13/2024 - 06:34 PM
BUSINESS WIRE
PACS Group, Inc. Reports First Quarter 2024 Results
05/13/2024 - 06:30 PM
BUSINESS WIRE
Pint Pharma anuncia a aprovação de ORLADEYO® (berotralstate), primeira terapia oral, indicada como prevenção das crises de angioedema hereditário (AEH) em adultos e pacientes pediátricos com 12 anos ou mais no Mexico
05/13/2024 - 06:24 PM
BUSINESS WIRE
Pint Pharma anuncia la aprobación de ORLADEYO® (berotralstat), la primera terapia oral indicada para prevenir los ataques de angioedema hereditario (HAE) en pacientes adultos y pediátricos de 12 años en adelante en Mexico.
05/13/2024 - 06:23 PM
BUSINESS WIRE
Pint Pharma Announces the Approval of ORLADEYO® (berotralstat), the First Oral Therapy Indicated for Preventing Hereditary Angioedema (HAE) Attacks in Adult and Pediatric Patients Aged 12 and Older in Mexico
05/13/2024 - 06:23 PM
BUSINESS WIRE
1
2
3
4
5
6
7
8
9
10
11
...
1645
« Previous
Next »